HMG-CoA Reductase Inhibitor

Established Pharmacologic Class (EPC) Comparison, United States, 2018

Total Prescriptions in (2018)

Drug Name Total Prescriptions (2018) Percent Share
Atorvastatin 112,474,024 51.3%
Simvastatin 48,007,044 21.9%
Rosuvastatin 24,138,061 11%
Pravastatin Sodium 24,022,032 11%
Lovastatin 8,769,144 4%
Pitavastatin 1,024,672 0.5%
Ezetimibe; Simvastatin 882,198 0.4%

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2008-2018. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 21.1. Read more about the ClinCalc DrugStats database.

All ClinCalc DrugStats figures and graphs on this page are licensed under Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0).


Related Links

Follow Us!

New and Popular


Open Menu

Cite This Page

Show AMA citation

Which of these drugs is contraindicated in pregnancy? The Top 250 Drugs by ClinCalc Academy
©2021 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Jan 18, 2021
Back to Top